...
首页> 外文期刊>Journal of psychosocial nursing and mental health services >Weight gain with atypical antipsychotic drugs in bipolar disorder.
【24h】

Weight gain with atypical antipsychotic drugs in bipolar disorder.

机译:双相障碍中有非典型抗精神病药物的体重增加。

获取原文
获取原文并翻译 | 示例

摘要

Diana is a 21-year-old student who lives with her parents. She had been enrolled in college but has taken a temporary leave of absence due to the instability of her bipolar disorder. Since being diagnosed at age 18, Diana's treatment team has been unable to find a medication regimen that would maintain her stability. She has had several breakthrough manic episodes that resulted in significant risky and inappropriate behaviors on campus. The cognitive, motivational, and energy limitations of depression left her unable to keep up with school requirements. Dr. Spiker, her regular psychiatrist, prescribed olanzapine Zyprexa 5 mg. Both Diana and Dr. Spiker are concerned about potential weight gain but consider this intervention necessary, as other medication trials have been unsuccessful.
机译:戴安娜是一名21岁的学生,与父母一起生活。 她在大学里招生,但由于她的双相情感障碍的不稳定性,已经暂时休假。 自18岁以来,戴安娜的治疗团队已无法找到将保持她稳定的药物方案。 她有几个突破性的躁狂事件,导致校园内的风险显着,不当行为。 抑郁症的认知,励志和能量限制使她无法跟上学校要求。 尖顶博士,她的常规精神科医生,规定了Olanzapine Zyprexa 5毫克。 戴安娜和尖顶博士都担心潜在的体重增加,但考虑这种干预,因为其他药物试验一直不成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号